Nat Clin Pract Rheumatol. 2007 Apr;3(4):227-33.

Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?

Source

Dartmouth Medical School, Lebanon, NH 03756, USA. wfcr@dartmouth.edu

Abstract

Antagonists of tumor necrosis factor (TNF) have revolutionized the treatment of selected inflammatory diseases. In rheumatology, this has been most notable for ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis. Despite their specificity for TNF, these agents, which include the soluble p75 receptor etanercept and the anti-TNF antibodies adalimumab and infliximab, have demonstrated differential clinical efficacy in studies of rheumatoid arthritis; patients who do not respond to one antagonist often respond to another. Therapeutic disparity of these agents is also seen in specific diseases, most notably Crohn's disease. Differences in pharmacodynamics, pharmacokinetics and mechanisms of action, as well as disease heterogeneity, have been proposed to account for these effects. Reverse signaling by transmembrane TNF in response to anti-TNF antibodies, but not soluble receptor, might also influence the therapeutic response.

PMID:: 17396108; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Etanercept - HSDB

Supplemental Content

Related citations

Review Differentiating the efficacy of tumor necrosis factor inhibitors. [J Rheumatol Suppl. 2005]
Review Differentiating the efficacy of tumor necrosis factor inhibitors.
Haraoui B. J Rheumatol Suppl. 2005 Mar; 74:3-7.
Review [Autoimmune aspects of treatment with TNF-alpha inhibitors]. [Postepy Hig Med Dosw (Online). 2007]
Review [Autoimmune aspects of treatment with TNF-alpha inhibitors].
Kolarz B, Targońska-Stepniak B, Darmochwał-Kolarz D, Majdan M. Postepy Hig Med Dosw (Online). 2007 Aug 28; 61:478-84. Epub 2007 Aug 28.
Review Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases. [Arthritis Res. 2002]
Review Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.
Kalden JR. Arthritis Res. 2002; 4 Suppl 2:S34-40. Epub 2002 May 24.
Review Infliximab induced T lymphocyte apoptosis in Crohn's disease. [J Rheumatol Suppl. 2005]
Review Infliximab induced T lymphocyte apoptosis in Crohn's disease.
van den Brande J, Hommes DW, Peppelenbosch MP. J Rheumatol Suppl. 2005 Mar; 74:26-30.
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. [Arthritis Rheum. 2008]
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.
Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, To K, Harashima S, Hatta N, Harada M. Arthritis Rheum. 2008 May; 58(5):1248-57.

See reviews... See all...

Cited by 7 PubMed Central articles

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA? [Pediatr Rheumatol Online J. 2010]
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
Cron RQ, Beukelman T. Pediatr Rheumatol Online J. 2010 Aug 16; 8:23. Epub 2010 Aug 16.
Review Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. [Rheumatology (Oxford). 2010]
Review Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.
Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Rheumatology (Oxford). 2010 Jul; 49(7):1215-28. Epub 2010 Mar 1.
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences. [Biologics. 2008]
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.
Stoll ML, Gotte AC. Biologics. 2008 Jun; 2(2):229-52.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Drug insight: different mechanisms of action of tumor necrosis factor antagonist...
Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?
Nat Clin Pract Rheumatol. 2007 Apr ;3(4):227-33.

PubMed
Surgical confusions in ophthalmology.
Surgical confusions in ophthalmology.
Arch Ophthalmol. 2007 Nov ;125(11):1515-22.

PubMed
An ordinary differential equation model for the multistep transformation to canc...
An ordinary differential equation model for the multistep transformation to cancer.
J Theor Biol. 2004 Dec 21 ;231(4):515-24.

PubMed
An open-label pilot study of high-concentration capsaicin patch in painful HIV n...
An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
J Pain Symptom Manage. 2008 Mar ;35(3):299-306. Epub 2007 Oct 23 .

PubMed
Quantifying myosin light chain phosphorylation in single adherent cells with aut...
Quantifying myosin light chain phosphorylation in single adherent cells with automated fluorescence microscopy.
BMC Cell Biol. 2007 Oct 17 ;8:43.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: